Evaluate the Safety and Feasibility of Same-Day Bilateral Epithelium-On Corneal Cross-Linking for Keratoconus

Recruiting now · Phase 4

Conditions studied: Keratoconus

In brief

Clinical trial to evaluate the safety and feasibility of corneal cross-linking in both eyes on the same day in subjects with keratoconus.

Key facts

Study ID

NCT07629557

Run by

Glaukos Corporation

People needed

15

Starts

2026-05-11

Expected to finish

2027-09-01

Last updated by the study team

2026-06-05

Who can join

Age: 13 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Provide written informed consent
• Willing and able to comply with study instructions and follow-up visits
• Diagnosis of keratoconus in each eye

You may not qualify if…

• Known allergy or sensitivity to study medications
• History of corneal disease
• Prior corneal cross-linking in either eye
• Pregnant, nursing, or planning pregnancy during the study period
• Participated in other investigational drug or device trial within 30 days of the study

Where it is running

• Glaukos Investigative Site — Westerville, Ohio, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.